News from all angles
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results f…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network